Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan · Delayed Price · Currency is TWD 140.00
-1.00 (-0.71%)
Apr 17, 2026, 1:30 PM CST
TPEX:6712 Market Cap
TPEX:6712 has a market cap or net worth of 12.26 billion as of April 17, 2026. Its market cap has decreased by -15.53% in one year.
Market Cap
12.26B
Enterprise Value
11.87B
Revenue
1.02B
Ranking
n/a
PE Ratio
28.69
Stock Price
140.00
Market Cap Chart
Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 12.26B, an increase of 140.65%. That is a compound annual growth rate of 12.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 12.26B | -14.63% |
| Dec 31, 2025 | 14.37B | 1.47% |
| Dec 31, 2024 | 14.16B | -1.25% |
| Dec 29, 2023 | 14.34B | -4.57% |
| Dec 30, 2022 | 15.02B | 15.46% |
| Dec 30, 2021 | 13.01B | 32.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AP Biosciences | 16.69B |
| Polaris Group | 16.17B |
| Medigen Vaccine Biologics | 15.78B |
| EirGenix | 15.31B |
| TaiMed Biologics | 14.56B |
| CHO Pharma | 11.56B |
| Tanvex BioPharma | 10.86B |
| Locus Cell | 10.22B |